Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2021

  • QYR655357
  • 124 Pages
  • August 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies sales (consumption) of Non-steroidal Anti-inflammatory Drugs (NSAID) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Bayer (DE)

Novacap (FR)

Abbott

Pfizer Inc

Geri-Care Pharmaceuticals

Perrigo Company

Kopran Ltd.

Merck Sharp & Dohme Corp.

Sun Pharmaceutical Industries Ltd

GlaxoSmithKline

Reddy Pharmaceuticals Ltd

Johnson & Johnson

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Aspirin

Ibuprofen

Naproxen

Nabumetone

Others

Split by applications, this report focuses on sales, market share and growth rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in each application, can be divided into

Back pain treatment

Osteoarthritis treatment

Other disease treatment

Table of Contents

United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2021

1 Non-steroidal Anti-inflammatory Drugs (NSAID) Overview

1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)

1.2 Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)

1.2.1 Aspirin

1.2.2 Ibuprofen

1.2.3 Naproxen

1.2.4 Nabumetone

1.2.5 Others

1.3 Applications of Non-steroidal Anti-inflammatory Drugs (NSAID)

1.3.1 Back pain treatment

1.3.2 Osteoarthritis treatment

1.3.3 Other disease treatment

1.4 USA Market Size (Value and Volume) of Non-steroidal Anti-inflammatory Drugs (NSAID) (2011-2021)

1.4.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Price (2011-2021)

1.4.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2021)

1.4.3 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)

2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Competition by Manufacturers

2.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Manufactures (2015 and 2016)

3 USA Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Type

3.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2011-2021)

3.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2011-2021)

4 USA Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume) by Application

5 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Analysis

5.1 Bayer (DE)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type and Technology

5.1.2.1 Aspirin

5.1.2.2 Ibuprofen

5.1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Bayer (DE) (2015 and 2016)

5.2 Novacap (FR)

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Aspirin

5.2.2.2 Ibuprofen

5.2.3 Pharmaceuticals Sales, Revenue, Price of Novacap (FR) (2015 and 2016)

5.3 Abbott

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Abbott Product Type and Technology

5.3.2.1 Aspirin

5.3.2.2 Ibuprofen

5.3.3 Abbott Sales, Revenue, Price of Abbott (2015 and 2016)

5.4 Pfizer Inc

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Sun Pharmaceutical Industries Ltd Product Type and Technology

5.4.2.1 Aspirin

5.4.2.2 Ibuprofen

5.4.3 Pfizer Inc Sales, Revenue, Price of Pfizer Inc (2015 and 2016)

5.5 Geri-Care Pharmaceuticals

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Geri-Care Pharmaceuticals Product Type and Technology

5.5.2.1 Aspirin

5.5.2.2 Ibuprofen

5.5.3 Geri-Care Pharmaceuticals Sales, Revenue, Price of Geri-Care Pharmaceuticals (2015 and 2016)

5.6 Perrigo Company

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Perrigo Company Product Type and Technology

5.6.2.1 Aspirin

5.6.2.2 Ibuprofen

5.6.3 Perrigo Company Sales, Revenue, Price of Perrigo Company (2015 and 2016)

5.7 Kopran Ltd.

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Kopran Ltd. Product Type and Technology

5.7.2.1 Aspirin

5.7.2.2 Ibuprofen

5.7.3 Kopran Ltd. Sales, Revenue, Price of Kopran Ltd. (2015 and 2016)

5.8 Merck Sharp & Dohme Corp.

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Merck Sharp & Dohme Corp. Product Type and Technology

5.8.2.1 Aspirin

5.8.2.2 Ibuprofen

5.8.3 Merck Sharp & Dohme Corp. Sales, Revenue, Price of Merck Sharp & Dohme Corp. (2015 and 2016)

5.9 Sun Pharmaceutical Industries Ltd

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Sun Pharmaceutical Industries Ltd Product Type and Technology

5.9.2.1 Aspirin

5.9.2.2 Ibuprofen

5.9.3 Sun Pharmaceutical Industries Ltd Sales, Revenue, Price of Sun Pharmaceutical Industries Ltd (2015 and 2016)

5.10 GlaxoSmithKline

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 GlaxoSmithKline Product Type and Technology

5.10.2.1 Aspirin

5.10.2.2 Ibuprofen

5.10.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

5.11 Reddy Pharmaceuticals Ltd

5.12 Johnson & Johnson

6 Non-steroidal Anti-inflammatory Drugs (NSAID) Technology and Development Trend

6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Technology Analysis

6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)

Table Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)

Figure USA Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2015

Figure Aspirin Picture

Figure Ibuprofen Picture

Figure Naproxen Picture

Figure Nabumetone Picture

Figure Others Picture

Table Applications of Non-steroidal Anti-inflammatory Drugs (NSAID)

Figure USA Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application in 2015

Figure Back pain treatment Examples

Figure Osteoarthritis treatment Examples

Figure Other disease treatment Examples

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Price (2011-2021)

Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2021)

Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales of Key Manufacturers (2015 and 2016)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers

Figure 2016 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2015 and 2016)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers

Table 2016 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2011-2021)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2011-2021)

Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2011-2021)

Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Type (2011-2021)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2011-2021)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2011-2021)

Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Type (2011-2021)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application (2011-2021)

Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2011-2021)

Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2011-2021)

Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Application (2011-2021)

Table Bayer (DE) Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Bayer (DE) (2015 and 2016)

Table Novacap (FR) Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Novacap (FR) (2015 and 2016)

Table Abbott Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Abbott (2015 and 2016)

Table Pfizer Inc Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Pfizer Inc (2015 and 2016)

Table Geri-Care Pharmaceuticals Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Geri-Care Pharmaceuticals (2015 and 2016)

Table Perrigo Company Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Perrigo Company (2015 and 2016)

Table Kopran Ltd. Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Kopran Ltd. (2015 and 2016)

Table Merck Sharp & Dohme Corp. Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Merck Sharp & Dohme Corp. (2015 and 2016)

Table Sun Pharmaceutical Industries Ltd Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Sun Pharmaceutical Industries Ltd (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Reddy Pharmaceuticals Ltd Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Reddy Pharmaceuticals Ltd (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390